Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Alves

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
NPJ Parkinson'S Disease|August 20, 2024
Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson's DiseaseCamilla Christina Pedersen, Anastasia Ushakova, Guido Alves, et al.
Neurobiology of Aging|December 20, 2017
Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's diseaseGonzalo S Nido, Christian Dölle, Irene Flønes, et al.
Archives of Neurology|August 11, 2010
A 12-year population-based study of psychosis in Parkinson diseaseElin B Forsaa, Jan Petter Larsen, Tore Wentzel-Larsen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2023
Inflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative DisordersCamilla Christina Pedersen, Anastasia Ushakova, Ragnhild Eide Skogseth, et al.
Acta Neuropathologica Communications|April 23, 2020
Common gene expression signatures in Parkinson's disease are driven by changes in cell compositionGonzalo S Nido, Fiona Dick, Lilah Toker, et al.
Parkinson'S Disease|January 21, 2016
Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian PopulationJohannes Lange, Kristin Aaser Lunde, Camilla Sletten, et al.
The Lancet. Neurology|June 13, 2009
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trialDag Aarsland, Clive Ballard, Zuzana Walker, et al.
Parkinsonism & Related Disorders|February 8, 2018
Evolution of cerebrospinal fluid total α-synuclein in Parkinson's diseaseMarthe Gurine Førland, Annika Öhrfelt, Ingvild Dalen, et al.
Molecular Neurodegeneration|May 5, 2021
Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brainLilah Toker, Gia T Tran, Janani Sundaresan, et al.
Neuroscience Letters|September 12, 2021
The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational studyJanete Chung, Anastasia Ushakova, Maria Doitsidou, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
NPJ Parkinson'S Disease|August 20, 2024
Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson's DiseaseCamilla Christina Pedersen, Anastasia Ushakova, Guido Alves, et al.
Neurobiology of Aging|December 20, 2017
Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's diseaseGonzalo S Nido, Christian Dölle, Irene Flønes, et al.
Archives of Neurology|August 11, 2010
A 12-year population-based study of psychosis in Parkinson diseaseElin B Forsaa, Jan Petter Larsen, Tore Wentzel-Larsen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2023
Inflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative DisordersCamilla Christina Pedersen, Anastasia Ushakova, Ragnhild Eide Skogseth, et al.
Acta Neuropathologica Communications|April 23, 2020
Common gene expression signatures in Parkinson's disease are driven by changes in cell compositionGonzalo S Nido, Fiona Dick, Lilah Toker, et al.
Parkinson'S Disease|January 21, 2016
Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian PopulationJohannes Lange, Kristin Aaser Lunde, Camilla Sletten, et al.
The Lancet. Neurology|June 13, 2009
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trialDag Aarsland, Clive Ballard, Zuzana Walker, et al.
Parkinsonism & Related Disorders|February 8, 2018
Evolution of cerebrospinal fluid total α-synuclein in Parkinson's diseaseMarthe Gurine Førland, Annika Öhrfelt, Ingvild Dalen, et al.
Molecular Neurodegeneration|May 5, 2021
Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brainLilah Toker, Gia T Tran, Janani Sundaresan, et al.
Neuroscience Letters|September 12, 2021
The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational studyJanete Chung, Anastasia Ushakova, Maria Doitsidou, et al.
Pageof 12